COX-2 (C295) Anti-Human Rabbit IgG Affinity Purify 18515 from IBL- America | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
IBL- America for
COX-2 (C295) Anti-Human Rabbit IgG Affinity Purify

IBL- America's COX-2 (C295) Anti-Human Rabbit IgG Affinity Purify is a Rabbit Polyclonal antibody. This antibody has been shown to work in applications such as: Immunohistochemistry, and Western Blot.

Description

This antibody can be stained in formalin fixed paraffin embedded tissues after microwave treatment. The optimal dilution is 2-10µg/ml, however, the dilution rate should be optimized by each laboratories. This antibody can be used for western blotting in concentration of 2-5µg/ml

Product Specs
ItemCOX-2 (C295) Anti-Human Rabbit IgG Affinity Purify
CompanyIBL- America
Price $596.00Supplier Page View Company Product Page
Catalog Number18515
ApplicationsIHC, WB
HostRabbit
IsotypeIgG
Regulatory StatusFor research use only, not for use in diagnostic procedures
ClonalityPolyclonal
ReactivityHuman (Hu)
FormatLyophilized product from 1% BSA in PBS containing 0.05%NaN3
PurityAffinity Purified with synthetic peptide
ImmunogenSynthetic peptide for a part of Human COX-2
StorageLyophilized product, 5 years at 2 - 8 °C, Solution, 2 years at -20 °C
Quantity100 ug

Add to Compare List

IBL- America

IBL- America

8201 Central Ave NE Suite P

Minneapolis, Minnesota 55432

United States

Phone: 888-523-1246
763-780-2988

Company Profile

Website: http://www.ibl-america.com/

(1) Pathological significance and prognostic implications of heme oxygenase 1 expression in non-muscle-invasive bladder cancer: Correlation with cell proliferation, angiogenesis, lymphangiogenesis and expression of VEGFs and COX-2Oncology lettersJanuary 1, 2017Matsuo T, Miyata Y, Mitsunari K, Yasuda T, Ohba K, Sakai H.#MAB286; dilution, 1:100); and anti‑COX‑2 (Immuno‑Biological Laboratories Co., Ltd., Gunma, Japan; #18515; dilution, 1:40). Tissue sections (thickness, 5 µm) were deparaffinized in xylene and rehydrated in

(2) Correlation among 16 biological factors [p53, p21(waf1), MIB-1 (Ki-67), p16(INK4A), cyclin D1, E-cadherin, Bcl-2, TNF-α, NF-κB, TGF-β, MMP-7, COX-2, EGFR, HER2/neu, ER, and HIF-1α] and clinical outcomes following curative chemoradiation therapy in 10 patients with esophageal squamous cell carcinomaOncology LettersMarch 1, 2013SHINO SHIBATA-KOBAYASHI, HIDEOMI YAMASHITA, KAE OKUMA, KENSHIRO SHIRAISHI, HIROSHI IGAKI, KUNI OHTOMO, KEIICHI NAKAGAWA4°C",Cytoplasmic MMP-7,Rabbit PC,"AB19135, Chemicon International",None,1:500,"Overnight, 4°C",Cytoplasmic COX-2,Rabbit PC,"18515, IBL",None,0.5μg/ml,"Overnight, 4°C",Cytoplasmic EGFR,Mouse MC,"K1492, DAKO",Proteinase K (kit),R-to-U,"30

Be the First to Write a Review!